uniQure NV (QURE)
22.69
-0.02
(-0.11%)
USD |
NASDAQ |
Oct 21, 16:00
23.88
+1.19
(+5.24%)
Pre-Market: 07:59
uniQure Profit Margin (Quarterly) : -1.39K% for June 30, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -1.39K% |
| March 31, 2026 | -1.50K% |
| December 31, 2025 | -666.1% |
| September 30, 2025 | -2.18K% |
| June 30, 2025 | -716.8% |
| March 31, 2025 | -2.78K% |
| December 31, 2024 | -1.40K% |
| September 30, 2024 | -1.94K% |
| June 30, 2024 | -506.0% |
| March 31, 2024 | -773.3% |
| December 31, 2023 | -1.09K% |
| September 30, 2023 | -6.37K% |
| June 30, 2023 | -2.83K% |
| March 31, 2023 | -1.45K% |
| December 31, 2022 | 6.63% |
| September 30, 2022 | -3.30K% |
| June 30, 2022 | -7.86K% |
| March 31, 2022 | -2.60K% |
| December 31, 2021 | 14.23% |
| September 30, 2021 | -1.84K% |
| June 30, 2021 | 86.12% |
| March 31, 2021 | -9.15K% |
| December 31, 2020 | -2.05% |
| September 30, 2020 | -3.01K% |
| June 30, 2020 | -2.77K% |
| Date | Value |
|---|---|
| March 31, 2020 | -26.92K% |
| December 31, 2019 | -1.58K% |
| September 30, 2019 | -2.26K% |
| June 30, 2019 | -1.27K% |
| March 31, 2019 | -2.44K% |
| December 31, 2018 | -1.36K% |
| September 30, 2018 | -700.0% |
| June 30, 2018 | -675.1% |
| March 31, 2018 | -540.2% |
| December 31, 2017 | -1.06K% |
| September 30, 2017 | -453.3% |
| June 30, 2017 | -430.4% |
| March 31, 2017 | -610.4% |
| December 31, 2016 | |
| September 30, 2016 | -211.5% |
| June 30, 2016 | -490.5% |
| March 31, 2016 | -519.2% |
| December 31, 2015 | -397.2% |
| September 30, 2015 | -820.5% |
| June 30, 2015 | -1.17K% |
| March 31, 2015 | -1.14K% |
| December 31, 2014 | -758.2% |
| September 30, 2014 | -905.0% |
| June 30, 2014 | -862.8% |
| March 31, 2014 | -669.1% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Kymera Therapeutics, Inc. | -94.17% |
| Moderna, Inc. | -539.3% |
| Abivax SA | -- |
| GRAIL, Inc. | -246.7% |
| Arrowhead Pharmaceuticals, Inc. | -237.8% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -140.6% |
| Return on Assets | -31.04% |
| Return on Invested Capital | -35.17% |
| Gross Profit Margin (Quarterly) | 10.00% |
| Operating Margin (Quarterly) | -899.6% |
| Return on Net Operating Assets | -176.6% |